A Response to Christopher Hood: 'The ethics of personal genetic profiling'

One aspect of the recently published Nuffield Council on Bioethics’ report on Medical Profiling and Online Medicine centred on the development of direct-toconsumer (DTC) personal genomic services, and is the focus of Hood’s commentary in this issue of GSP. We have been prompted to make a number of comments in response to this piece (rather than to the report in its entirety). We would first like to state clearly that the work of the Nuffield group is welcomed and its report is a very useful contribution to ongoing discussions amongst academics, policy makers, and public interest groups about developments in the personalisation and online provision of various healthcare products and services.